Adjuvante Therapie mit Olaparib bei BRCA1/2-assoziiertem Mammakarzinom

Translated title of the contribution: Adjuvant treatment with olaparib for BRCA1/2-associated breast cancer

Laura Dussan Molinos*, Natalia Krawczyk, Lars Hanker, Achim Rody, Maggie Banys-Paluchowski

*Corresponding author for this work
1 Citation (Scopus)
Translated title of the contributionAdjuvant treatment with olaparib for BRCA1/2-associated breast cancer
Original languageGerman
JournalOnkologe
Volume28
Issue number3
Pages (from-to)244-247
Number of pages4
ISSN0947-8965
DOIs
Publication statusPublished - 03.2022

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

DFG Research Classification Scheme

  • 2.22-21 Gynaecology and Obstetrics
  • 2.22-14 Hematology, Oncology

Cite this